Materials Map

Discover the materials research landscape. Find experts, partners, networks.

  • About
  • Privacy Policy
  • Legal Notice
  • Contact

The Materials Map is an open tool for improving networking and interdisciplinary exchange within materials research. It enables cross-database search for cooperation and network partners and discovering of the research landscape.

The dashboard provides detailed information about the selected scientist, e.g. publications. The dashboard can be filtered and shows the relationship to co-authors in different diagrams. In addition, a link is provided to find contact information.

×

Materials Map under construction

The Materials Map is still under development. In its current state, it is only based on one single data source and, thus, incomplete and contains duplicates. We are working on incorporating new open data sources like ORCID to improve the quality and the timeliness of our data. We will update Materials Map as soon as possible and kindly ask for your patience.

To Graph

1.080 Topics available

To Map

977 Locations available

693.932 PEOPLE
693.932 People People

693.932 People

Show results for 693.932 people that are selected by your search filters.

←

Page 1 of 27758

→
←

Page 1 of 0

→
PeopleLocationsStatistics
Naji, M.
  • 2
  • 13
  • 3
  • 2025
Motta, Antonella
  • 8
  • 52
  • 159
  • 2025
Aletan, Dirar
  • 1
  • 1
  • 0
  • 2025
Mohamed, Tarek
  • 1
  • 7
  • 2
  • 2025
Ertürk, Emre
  • 2
  • 3
  • 0
  • 2025
Taccardi, Nicola
  • 9
  • 81
  • 75
  • 2025
Kononenko, Denys
  • 1
  • 8
  • 2
  • 2025
Petrov, R. H.Madrid
  • 46
  • 125
  • 1k
  • 2025
Alshaaer, MazenBrussels
  • 17
  • 31
  • 172
  • 2025
Bih, L.
  • 15
  • 44
  • 145
  • 2025
Casati, R.
  • 31
  • 86
  • 661
  • 2025
Muller, Hermance
  • 1
  • 11
  • 0
  • 2025
Kočí, JanPrague
  • 28
  • 34
  • 209
  • 2025
Šuljagić, Marija
  • 10
  • 33
  • 43
  • 2025
Kalteremidou, Kalliopi-ArtemiBrussels
  • 14
  • 22
  • 158
  • 2025
Azam, Siraj
  • 1
  • 3
  • 2
  • 2025
Ospanova, Alyiya
  • 1
  • 6
  • 0
  • 2025
Blanpain, Bart
  • 568
  • 653
  • 13k
  • 2025
Ali, M. A.
  • 7
  • 75
  • 187
  • 2025
Popa, V.
  • 5
  • 12
  • 45
  • 2025
Rančić, M.
  • 2
  • 13
  • 0
  • 2025
Ollier, Nadège
  • 28
  • 75
  • 239
  • 2025
Azevedo, Nuno Monteiro
  • 4
  • 8
  • 25
  • 2025
Landes, Michael
  • 1
  • 9
  • 2
  • 2025
Rignanese, Gian-Marco
  • 15
  • 98
  • 805
  • 2025

Nobelen, Tim Van Den

  • Google
  • 1
  • 5
  • 0

in Cooperation with on an Cooperation-Score of 37%

Topics

Publications (1/1 displayed)

  • 2023Empowering Antibiotics In The Amr Landscape: Insights From Dendrimer Conjugation In Ali Systemscitations

Places of action

Chart of shared publication
Molin, Søren
1 / 4 shared
Martinenghi, Laura Daniela
1 / 1 shared
Leisner, Jørgen J.
1 / 1 shared
Christensen, Jørn Bolstad
1 / 7 shared
Johansen, Helle Krogh
1 / 3 shared
Chart of publication period
2023

Co-Authors (by relevance)

  • Molin, Søren
  • Martinenghi, Laura Daniela
  • Leisner, Jørgen J.
  • Christensen, Jørn Bolstad
  • Johansen, Helle Krogh
OrganizationsLocationPeople

document

Empowering Antibiotics In The Amr Landscape: Insights From Dendrimer Conjugation In Ali Systems

  • Nobelen, Tim Van Den
  • Molin, Søren
  • Martinenghi, Laura Daniela
  • Leisner, Jørgen J.
  • Christensen, Jørn Bolstad
  • Johansen, Helle Krogh
Abstract

<div>In the shadow of the AMR crisis, reigniting the antibiotic pipeline has emerged as a pivotal strategy. Despite the urgent need, there has been a decrease in finding new types of natural or synthetic antibiotics over the past forty years. Of the 65 antibiotics introduced in the last two decades, only four were genuinely new pharmacological classes, whilst the remainder were merely derivatives or modifications of pre-existing compounds. This challenge arises from the need to bypass bacterial resistance, which, paradoxically, is also the target.<br/></div><div><br/></div><div>Inspired by a 2006 study that successfully integrated propranolol with a known drug delivery polymer, DAB-PAMAM dendrimer, for enhanced cellular uptake, we advanced this approach by conjugating the antibiotic ciprofloxacin with PAMAM dendrimers. This strategy aims to enhance the antibiotic’s effectiveness by preventing its ejection from cells.</div><br/><div>The screening results were promising as <i>Escherichia coli </i>showed MIC values of 1.25 µg/µl and <i>Pseudomonas aeruginosa</i> 1-2 µg/µl. <i>Staphylococcus aureus</i> exhibited values, oscillating between 2-4 µg/µl. MIC values, which lowered by a factor of 2 when tested in media other than MHB. The compounds did not result in cytotoxicity nor hemolysis.</div><div><br/></div>An important outcome of these experiments was the insight that tackling AMR requires not only identification of suitable candidates, but also require that standardized screening methodologies are in congruence with clinical needs. Therefore, we employed an air-liquid interface (ALI) culture set-up to mimic respiratory epithelial cells’ natural environment. By introducing<i> P. aeruginosa</i>, a severe cause of respiratory infections, we sought to compare its behavior with standard lab screenings, aiming to bridge the gap between conventional lab methods and clinical needs inside the antimicrobial development pipeline.

Topics
  • impedance spectroscopy
  • compound
  • polymer
  • experiment
  • dendrimer